Document Classification

Section Type: RESULTS

Text: Over a median follow-up of 4. 5 years, 18 patients (13 %) on VeraTran vs. 15 (10. 5 %) on trandolapril [unadjusted hazard ratio (95 % confidence interval [CI]) 1. 07 (0. 54-2. 12), P = 0. 852] progressed to macroalbuminuria, respectively ; 62 (44. 9 %) vs. 71 (49. 7 %) [0. 80 (0. 57-1. 12), P = 0. 198] regressed to normoalbuminuria (urinary albumin excretion < 20 g/min), and 20 (14. 5 %) vs. 21 (14. 7 %) [hazard ratio 0. 93 (0. 50-1. 72), P = 0. 816] had major cardiovascular events.